IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV12I3A65

Microprobe transoesophageal echocardiographic guidance during transcatheter interatrial septal device implantation in heart failure with a preserved ejection fraction

Roel J.R. Snijder*, MD; Martin J. Swaans, MD, PhD; Jan A.S. van der Heyden, MD, PhD; Martijn C. Post, MD, PhD

Ao: aorta; LA: left atrium; RA: right atrium; SVC: superior vena cava

A 73-year-old male with a history of transient ischaemic attack, paroxysmal atrial fibrillation and heart failure with a preserved ejection fraction (HFPEF) was seen in the outpatient clinic with severe symptoms of heart failure despite optimal medical therapy. Prior to study inclusion (REDUCE-LAP trial) a heart catheterisation had been performed. The coronary angiogram showed only a significant stenosis of a small ramus descendens posterior.

Pulmonary hypertension (mean pulmonary artery pressure 34 mmHg) with an increased wedge pressure (21 mmHg) was present. The patient gave informed consent and was accepted for interatrial septal device (IASD®; DC Devices, Inc., Tewksbury, MA, USA) implantation in order to lower left atrial pressure. The procedure was performed under local anaesthesia and microprobe transoesophageal echocardiography (mTEE) guidance (S8-3t sector array multiplane microTEE; Philips Healthcare, Best, The Netherlands). A transseptal puncture via the transfemoral access was performed as seen in the mid-oesophageal bicaval view in Panel A (arrow). Subsequently, the IASD was implanted with the occurrence of a continuous left-to-right atrial flow through the device. Panel B shows, using the mid-oesophageal short-axis at the base view, the implanted IASD with left-to-right flow using colour Doppler (arrows). Panel C indicates permanent left-to-right shunt using continuous wave Doppler. The per-procedural fluoroscopic image (Panel D) shows the IASD and the microprobe (respectively black and white arrow).

The procedure and hospitalisation were uncomplicated. The use of mTEE was easy and safe. The handling of the mTEE probe was similar when compared to standard TEE. Though the images from the mTEE had a lower resolution, they were good enough for transcatheter (atrial) intervention, such as IASD implantation. All necessary views could be recorded, except for three-dimensional images.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 12 Number 3
Jun 20, 2016
Volume 12 Number 3
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV12SXA17 May 16, 2016
Creating interatrial shunts in heart failure and pulmonary hypertension
Wolsk E and Gustafsson F
free

Expert review

10.4244/EIJ-D-18-01211 Jun 20, 2019
Interatrial shunting for heart failure: current evidence and future perspectives
Guimarães L et al
free

SPECIAL REPORT

10.4244/EIJY15M07_08 Oct 20, 2015
Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension
Patel M et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00873 Aug 28, 2020
A novel implantable left atrial sensor for pressure monitoring in heart failure
Di Mario C et al
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00164 Jun 20, 2017
First transjugular edge-to-edge mitral valve repair with the MitraClip system
Fam N et al
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
38.95

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved